Nir Barak new

Nir Barak, MD

Chief Medical Advisor

Dr. Barak serves as the Chief Medical Advisor of Theraimmune since October 2023. Previously he served as the Chief scientific Officer of 9 Meters Biopharma, Inc. (Nasdaq: NMTR), a company focused on rare and unmet needs in gastrointestinal patient populations developing compounds with unique gastrointestinal biology. In 2008, after 10 years of working as an attending in Internal Medicine in a major hospital, Dr Barak founded RDD Pharma, a company focused on repurposing of drugs for anorectal indications. Under his leadership, RDD Pharma raised an investment from Orbimed, and in 2019 the company was merged to form 9 Meters Biopharma. Dr Barak received his MD from Tel-Aviv University, is board certified in Internal Medicine and completed 2 years of post-doctoral fellowship in the University of Chicago Hospitals.